Report of Foreign Issuer (6-k)
November 10 2016 - 6:54AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2016
Commission File Number: 001-36582
Auris Medical Holding AG
(Exact name of registrant as specified
in its charter)
Bahnhofstrasse 21
6300 Zug, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
INCORPORATION BY REFERENCE
Exhibits 99.1, 99.2 and 99.3 to this Report on Form 6-K
shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-206710)
and Form S-8 (Registration Numbers 333-198037 and 333-200805) of Auris Medical Holding AG and to be a part thereof from the
date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Exhibit 99.4 to this Report on Form 6-K shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or
otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act.
RISK FACTORS
The risk factors set forth in Exhibit 99.3 filed herewith supplement
and update certain risk factors in the discussion of material risks in Item 3.D of our Annual Report on Form 20-F for the fiscal
year ended December 31, 2015. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial,
also may affect our business, financial condition and/or future operating results.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
Auris Medical Holding AG
|
|
|
|
By:
|
/s/ Thomas Meyer
|
|
|
|
|
Name:
|
Thomas Meyer
|
|
|
|
|
Title:
|
Chief Executive Officer
|
Date: November 10, 2016
EXHIBIT INDEX
Exhibit Number
|
Description
|
99.1
|
Unaudited Condensed Consolidated Interim Financial Statements
|
99.2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
99.3
|
Updated Risks Related to the Development and Clinical Testing of our Product Candidates and Risks
Related to Regulatory Approval of our Product Candidates.
|
99.4
|
Press Release dated November 10, 2016
|
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2023 to Apr 2024